ArticleOncoTargets and therapy2015

BMS-536924, an ATP-competitive IGF-1R/IR inhibitor, decreases viability and migration of temozolomide-resistant glioma cells in vitro and suppresses tumor growth in vivo.

Qiao ZhouPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.